MedPath

The effect of chamomile tea on anxiety and depression in postmenopausal wome

Not Applicable
Recruiting
Conditions
Anxiety and depression in postmenopausal women..
Anxiety disorder due to known physiological condition
F06.4
Registration Number
IRCT20200818048452N1
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
68
Inclusion Criteria

Interested in participating in the study.
Having at least elementary education.
45-60 years old.
Amenorrhea for 1 year.
Mild to moderate anxiety and depression symptoms (according DASS scale).

Exclusion Criteria

Having allergy to chamomile.
Major depression that need to special treatment.
Person who have suicidal thoughts and self-harm.
Having renal, liver, cardiac and thyroid disease, Bleeding disorder and malignancies, degenerative, auto immune and psychological disorder.
Using of anti-depression and sedative drugs in 3 months ago.
Having a history of stressful events or tragic events in recent months such as the death of a spouse or close persons.
Having a history of drug abuser or alcohol abuse.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Anxiety and depression in postmenopausal women. Timepoint: Pre-intervention, 4 weeks after the start of the intervention, 8 weeks after the start of the intervention. Method of measurement: Variables are measured by demographic questionnaire and DAAS-21 scale.
Secondary Outcome Measures
NameTimeMethod
Anxiety and depression in postmenopausal women. Timepoint: Pre-intervention, 4 weeks after the start of the intervention, 8 weeks after the start of the intervention. Method of measurement: Variables are measured by demographic questionnaire and DAAS-21 scale.
© Copyright 2025. All Rights Reserved by MedPath